Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1166 ARTÍCULOS , VIENDO DEL 946 AL 960

Aβ Influences Cytoskeletal Signaling Cascades with Consequences to Alzheimer's Disease

Henriques AG, Oliveira JM, Carvalho LP, da Cruz E Silva OAB.

Mol Neurobiol. 2015 Dec;52(3):1391-1407. doi: 10.1007/s12035-014-8913-4. Epub 2014 Oct 26.

Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain

Darbà J, Kaskens L, Lacey L.

Eur J Health Econ. 2015 Nov;16(8):895-905. doi: 10.1007/s10198-014-0642-0. Epub 2014 Oct 28.

From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration

Zhao Y, Gong CX.

Cell Mol Neurobiol. 2015 Jan;35(1):101-10. doi: 10.1007/s10571-014-0127-9. Epub 2014 Oct 29.

Effect of rivastigmine or memantine add-on therapy is affected by butyrylcholinesterase genotype in patients with probable Alzheimer's disease

Han HJ, Kwon JC, Kim JE, Kim SG, Park JM, Park KW, Park KC, Park KH, Moon SY, Seo SW, Choi SH, Cho SJ.

Eur Neurol. 2015;73(1-2):23-8. doi: 10.1159/000366198. Epub 2014 Nov 1.

ATF4: a Novel Potential Therapeutic Target for Alzheimer's Disease

Wei N, Zhu LQ, Liu D.

Mol Neurobiol. 2015 Dec;52(3):1765-1770. doi: 10.1007/s12035-014-8970-8. Epub 2014 Nov 9.

Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer's disease

Cagnin A, Cester A, Costa B, Ermani M, Gabelli C, Gambina G; SWITCH study working group.

Neurol Sci. 2015 Mar;36(3):457-63. doi: 10.1007/s10072-014-2002-3. Epub 2014 Nov 14.

Role of insulin resistance in Alzheimer's disease

Cai Z, Xiao M, Chang L, Yan LJ.

Metab Brain Dis. 2015 Aug;30(4):839-51. doi: 10.1007/s11011-014-9631-3. Epub 2014 Nov 16.

Tropisetron and its targets in Alzheimer's disease

Hashimoto K.

Expert Opin Ther Targets. 2015 Jan;19(1):1-5. doi: 10.1517/14728222.2014.983901. Epub 2014 Nov 15.

What are the Benefits of Exercise for Alzheimer's Disease? A Systematic Review of the Past 10 Years

Hernández SS, Sandreschi PF, da Silva FC, Arancibia BA, da Silva R, Gutierres PJ, Andrade A.

J Aging Phys Act. 2015 Oct;23(4):659-68. doi: 10.1123/japa.2014-0180. Epub 2014 Nov 21.

Using the Alzheimer's Association web site to improve knowledge of Alzheimer's disease in health care providers

Hughes ML, Lowe DA, Shine HE, Carpenter BD, Balsis S.

Am J Alzheimers Dis Other Demen. 2015 Feb;30(1):98-100. doi: 10.1177/1533317514559827. Epub 2014 Nov 25.

A computational method for computing an Alzheimer's disease progression score; experiments and validation with the ADNI data set

Jedynak BM, Liu B, Lang A, Gel Y, Prince JL; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2015 Jan;36 Suppl 1:S178-84. doi: 10.1016/j.neurobiolaging.2014.03.043. Epub 2014 Oct 17.

Medical genetics-based drug repurposing for Alzheimer's disease

Zhang XZ, Quan Y, Tang GY.

Brain Res Bull. 2015 Jan;110:26-9. doi: 10.1016/j.brainresbull.2014.11.003. Epub 2014 Nov 22.

Improving the predictive value of interventional animal models data

Zeiss CJ.

Drug Discov Today. 2015 Apr;20(4):475-82. doi: 10.1016/j.drudis.2014.10.015. Epub 2014 Nov 4.

Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes

Shamseddine AA, Airola MV, Hannun YA.

Adv Biol Regul. 2015 Jan;57:24-41. doi: 10.1016/j.jbior.2014.10.002. Epub 2014 Oct 27.

Configuration-specific immunotherapy targeting cis pThr231-Pro232 tau for Alzheimer disease

Wang JZ, Zhang Y.

J Neurol Sci. 2015 Jan 15;348(1-2):253-5. doi: 10.1016/j.jns.2014.11.011. Epub 2014 Nov 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias